IBB UAB

Introduction

The Institut de Biotecnologia i de Biomedicina (IBB) was created in 1970 as a research institute of the Universitat Autònoma de Barcelona (UAB). Although the institute was originally devoted to promoting fundamental biological research, we have been focusing in the Biotechnology and Biomedicine fields for the last 20 years.

We conduct top-level scientific research with the mission to improve the health and quality of life of the population through the production and dissemination of scientific knowledge. Our researchers participate in high competitive calls, both national and internationally, aimed at funding basic and translational research.

Among the 200 researchers currently working at the IBB, there are lecturers and professors from the UAB, ICREA professors and senior researchers, postdoctoral fellows, and PhD and Master students. The IBB hosts 18 research groups organised into 3 scientific programmes covering different areas that include bioinformatics, cellular and structural biology, genomics, immunology, microbiology and proteomics.

Our multidisciplinary nature is one of the most relevant characteristics of the IBB and allows for a broad approach to biological problems in a vibrant scientific environment. The IBB researchers have expertise in different topics within the biomedicine and the biotechnology field.     

  The IBB is also highly engaged in training of researchers to an international standard and it is committed to the training of students, which will be key to future progress.

The IBB shares its in-campus building with biotech companies and technological platforms including Genomics and Bioinformatics (SGB), Proteomics and Structural Biology (SEPBioES) and Cytometry, Cell culture and Antibody Production (SCAC). These scientific facilities were born within the IBB and now they work offering their services to the IBB researchers, the UAB community and external users. 


   

Management Team (since March 2020)

Director: Dra. Nerea Roher
Manager: Eva Vila